49.87
price down icon8.73%   -4.77
after-market Handel nachbörslich: 49.87
loading
Schlusskurs vom Vortag:
$54.64
Offen:
$53.16
24-Stunden-Volumen:
6.76M
Relative Volume:
2.81
Marktkapitalisierung:
$7.82B
Einnahmen:
$1.17B
Nettoeinkommen (Verlust:
$150.71M
KGV:
53.05
EPS:
0.94
Netto-Cashflow:
$245.03M
1W Leistung:
-13.59%
1M Leistung:
-6.15%
6M Leistung:
-33.52%
1J Leistung:
-36.41%
1-Tages-Spanne:
Value
$47.66
$54.56
1-Wochen-Bereich:
Value
$47.66
$57.74
52-Wochen-Spanne:
Value
$46.01
$80.95

Bio Techne Corp Stock (TECH) Company Profile

Name
Firmenname
Bio Techne Corp
Name
Telefon
(612) 379-8854
Name
Adresse
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Name
Mitarbeiter
3,100
Name
Twitter
@biotechne
Name
Nächster Verdiensttermin
2024-10-30
Name
Neueste SEC-Einreichungen
Name
TECH's Discussions on Twitter

Vergleichen Sie TECH mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TECH
Bio Techne Corp
49.87 8.57B 1.17B 150.71M 245.03M 0.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
385.65 96.11B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.13 60.40B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
428.14 54.91B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
673.15 41.30B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
298.52 33.25B 3.81B -644.79M -669.77M -6.24

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-22 Fortgesetzt Stephens Overweight
2025-07-09 Eingeleitet TD Cowen Buy
2025-05-30 Eingeleitet Wells Fargo Overweight
2025-04-09 Herabstufung KeyBanc Capital Markets Overweight → Sector Weight
2025-03-18 Eingeleitet Evercore ISI Outperform
2025-02-19 Herabstufung Robert W. Baird Outperform → Neutral
2024-05-22 Herabstufung Citigroup Buy → Neutral
2024-02-08 Eingeleitet Scotiabank Sector Outperform
2024-02-02 Herabstufung Stifel Buy → Hold
2023-12-07 Eingeleitet UBS Buy
2023-08-28 Eingeleitet William Blair Outperform
2023-01-10 Hochstufung Wells Fargo Underweight → Equal Weight
2022-12-14 Eingeleitet Deutsche Bank Buy
2022-12-12 Hochstufung Citigroup Neutral → Buy
2022-12-07 Eingeleitet RBC Capital Mkts Sector Perform
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-04-25 Herabstufung Wells Fargo Equal Weight → Underweight
2021-09-15 Hochstufung KeyBanc Capital Markets Sector Weight → Overweight
2021-03-08 Hochstufung Stephens Equal-Weight → Overweight
2021-02-23 Hochstufung Stifel Hold → Buy
2021-01-25 Bestätigt The Benchmark Company Buy
2020-11-10 Eingeleitet KeyBanc Capital Markets Sector Weight
2020-09-30 Eingeleitet Atlantic Equities Overweight
2020-07-15 Herabstufung Stephens Overweight → Equal-Weight
2020-05-27 Herabstufung Stifel Buy → Hold
2020-05-14 Eingeleitet The Benchmark Company Buy
2020-01-08 Fortgesetzt Stephens Overweight
2020-01-08 Eingeleitet Wells Fargo Equal Weight
2020-01-07 Eingeleitet Citigroup Neutral
2019-11-15 Eingeleitet Stifel Buy
2019-07-02 Hochstufung Janney Neutral → Buy
2019-01-14 Hochstufung Stephens Equal-Weight → Overweight
2018-10-31 Herabstufung Craig Hallum Buy → Hold
2018-10-17 Eingeleitet Goldman Neutral
2018-06-15 Eingeleitet Argus Buy
2017-07-13 Eingeleitet Wells Fargo Market Perform
2017-02-09 Eingeleitet Citigroup Buy
2017-01-18 Eingeleitet Deutsche Bank Buy
2016-11-10 Fortgesetzt Leerink Partners Outperform
2015-01-21 Bestätigt Robert W. Baird Outperform
2013-09-20 Hochstufung Robert W. Baird Neutral → Outperform
Alle ansehen

Bio Techne Corp Aktie (TECH) Neueste Nachrichten

pulisher
Aug 06, 2025

Bio-Techne (TECH) Q4 EPS Rises 8.2% - The Motley Fool

Aug 06, 2025
pulisher
Aug 06, 2025

Bio-Techne takes a hit on Exodx sale to Mdxhealth - BioWorld MedTech

Aug 06, 2025
pulisher
Aug 06, 2025

Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MarketWatch

Aug 06, 2025
pulisher
Aug 06, 2025

Bio-Techne's Q4 Fiscal 2025 Results Trigger 6.5% Share DeclineNews and Statistics - IndexBox

Aug 06, 2025
pulisher
Aug 06, 2025

Why Bio-Techne (TECH) Shares Are Plunging Today - Yahoo Finance

Aug 06, 2025
pulisher
Aug 06, 2025

Earnings call transcript: Bio-Techne Q4 2025 beats EPS forecasts - Investing.com

Aug 06, 2025
pulisher
Aug 06, 2025

Bio-Techne Q2 2025 Financial Results: Revenue and EPS Surpass ExpectationsNews and Statistics - IndexBox

Aug 06, 2025
pulisher
Aug 06, 2025

Bio-Techne Corp reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2025
pulisher
Aug 06, 2025

Bio-Techne (NASDAQ:TECH) Exceeds Q2 Expectations - Yahoo Finance

Aug 06, 2025
pulisher
Aug 06, 2025

Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls - Nasdaq

Aug 06, 2025
pulisher
Aug 06, 2025

Bio-Techne Exceeds Forecasts And Refines Its Focus On Growth - Finimize

Aug 06, 2025
pulisher
Aug 06, 2025

Bio-Techne Q4 25 Earnings Conference Call At 9:00 AM ET - Nasdaq

Aug 06, 2025
pulisher
Aug 06, 2025

Techne (TECH) Beats Q4 Earnings and Revenue Estimates - Nasdaq

Aug 06, 2025
pulisher
Aug 06, 2025

Bio-Techne Corp (TECH) Q4 Earnings: Revenue Surpasses Estimates - GuruFocus

Aug 06, 2025
pulisher
Aug 06, 2025

Bio-Techne earnings beat by $0.03, revenue topped estimates - Investing.com Canada

Aug 06, 2025
pulisher
Aug 06, 2025

Bio-techne declares quarterly dividend of $0.08 per share - Investing.com

Aug 06, 2025
pulisher
Aug 06, 2025

Bio-Techne Earnings Beat Estimates as Cell Therapy Division Drives Growth, Strategic Divestiture Announced - Stock Titan

Aug 06, 2025
pulisher
Aug 06, 2025

Dividend Alert: Bio-Techne Sets $0.08 Per Share Payout, Reveals August Payment Timeline - Stock Titan

Aug 06, 2025
pulisher
Aug 05, 2025

Bio-techne to sell exosome diagnostics business to mdxhealth By Investing.com - Investing.com South Africa

Aug 05, 2025
pulisher
Aug 05, 2025

Bio-techne to sell exosome diagnostics business to mdxhealth - Investing.com

Aug 05, 2025
pulisher
Aug 05, 2025

Bio-Techne Sells Prostate Cancer Test Business to Strengthen Core Operations: Strategic Shift Revealed - Stock Titan

Aug 05, 2025
pulisher
Aug 05, 2025

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne - The Manila Times

Aug 05, 2025
pulisher
Aug 05, 2025

Bio-Techne Q4 Earnings Preview: What's in Store for the Stock? - MSN

Aug 05, 2025
pulisher
Aug 05, 2025

Stock Analysis | Bio-Techne OutlookWeak Technicals but Strong Fundamentals - AInvest

Aug 05, 2025
pulisher
Aug 04, 2025

Earnings To Watch: Bio-Techne (TECH) Reports Q2 Results Tomorrow - Yahoo Finance

Aug 04, 2025
pulisher
Aug 03, 2025

Why is Bio Techne Corporation stock attracting strong analyst attentionStay informed with daily expert analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives Bio Techne Corporation stock priceExponential wealth increase - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

When is Bio Techne Corporation stock expected to show significant growthGain insights from top financial experts - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is Bio Techne Corporation stock overvalued or undervaluedMassive profits - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

How strong is Bio Techne Corporation company’s balance sheetMaximize your returns with portfolio optimization - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Bio Techne Corporation Shows Risk Reward Favoring UpsideAccurate Buy Point for Momentum Stocks Detected - beatles.ru

Aug 02, 2025
pulisher
Aug 01, 2025

Is it the right time to buy Bio Techne Corporation stockAI Powered Growth Plan For 2025 - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

Bio-Techne Corporation (TECH) Slid on Weakness in Research Spending - Yahoo Finance

Aug 01, 2025
pulisher
Aug 01, 2025

Bio-Techne Corporation (TECH) Slid on Rise in Investors’ Concerns - Yahoo Finance

Aug 01, 2025
pulisher
Jul 31, 2025

ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering - Yahoo Finance

Jul 31, 2025
pulisher
Jul 30, 2025

Promising Long-Term Growth for Bio-Techne Amidst Current Challenges: A Buy Recommendation by Kyle Boucher - TipRanks

Jul 30, 2025
pulisher
Jul 29, 2025

Will Bio Techne Corporation stock benefit from interest rate changesLow Risk High Return Opportunities Identified - beatles.ru

Jul 29, 2025
pulisher
Jul 28, 2025

Momentum Screeners Rank Bio Techne Corporation in Top 5 TodayReal-Time Trade Insights Spark Market Reactions - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Why Bio Techne Corporation is moving today Weekly Setup Summary for Risk Controlled Trades - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate Bio Techne Corporation as a “Buy”Discover the fastest growing stocks today - Jammu Links News

Jul 28, 2025
pulisher
Jul 28, 2025

Bio-Techne Corporation (TECH) Gets Initiated With a New Buy Rating at TD Cowen - Insider Monkey

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Bio Techne Corporation stock price move sharplyAchieve rapid capital gains with smart investing - Jammu Links News

Jul 28, 2025
pulisher
Jul 27, 2025

Estimating The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH) - Yahoo Finance

Jul 27, 2025
pulisher
Jul 26, 2025

Bio-Techne’s Quarterly Earnings Preview: What You Need to Know - MSN

Jul 26, 2025
pulisher
Jul 25, 2025

10 Most Profitable Biotech Stocks to Invest in Now - Insider Monkey

Jul 25, 2025
pulisher
Jul 24, 2025

Bio-Techne Corporation (TECH): A Bull Case Theory - Yahoo Finance

Jul 24, 2025
pulisher
Jul 22, 2025

What analysts say about Bio Techne Corporation stockTriple returns potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Bio-Techne (TECH) Stock Is Up, What You Need To Know - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

Bio Techne Corporation Stock Analysis and ForecastFree Investment Community - Autocar Professional

Jul 22, 2025
pulisher
Jul 21, 2025

Bio-Techne Corporation shares rise 1.99% after-hours as US stocks close higher. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch

Jul 21, 2025

Finanzdaten der Bio Techne Corp-Aktie (TECH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.65
price down icon 0.10%
$37.12
price down icon 2.08%
$111.26
price down icon 0.31%
$28.52
price down icon 2.09%
$111.30
price up icon 0.21%
biotechnology ONC
$298.52
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):